Synergy Pharmaceuticals’ committee of unsecured creditors appointed

By Caroline Salls

Pittsburgh, Dec. 20 – Synergy Pharmaceuticals Inc.’s official committee of unsecured creditors was appointed Thursday by Region 2 U.S. trustee William K. Harrington, according to a notice filed with the U.S. Bankruptcy Court for the Southern District of New York.

The committee members are Patrick J. Healy of Wilmington Savings Fund Society, FSB of Wilmington, Del.; Damon P. Meyer of 1992 MSF International Ltd. of New York; Jack Triolo of Healix Global, Inc. of New York; Ben R. Carlsen of McKesson Corp. of Moon Township, Pa.; and Chris Borella of Sudler & Hennessy, LLC of New York.

Synergy is a New York-based biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies. The company filed bankruptcy on Dec. 12 under Chapter 11 case number 18-14010.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.